Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2411785Generated: November 4, 2026

(6-Bromopyridin-3-yl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone → 1-{5-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}-5,5-dimethylimidazolidin-2-one

https://huagongshe.com/reaction/2411785

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(6-Bromopyridin-3-yl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanoneHCID 58484661—
Reactant1-(4-Methoxybenzyl)-4,4-dimethylimidazolidin-2-oneHCID 71252673—
Product1-{5-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}-5,5-dimethylimidazolidin-2-oneHCID 71252026—
Product3-{5-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}-1-(4-methoxybenzyl)-4,4-dimethylimidazolidin-2-oneHCID 71252182—

Reaction Steps

Using (6-bromopyridin-3-yl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (150 mg) described in Preparation Example 127 and 1-(4-methoxybenzyl)-4,4-dimethylimidazolidin-2-one (112 mg) described in Preparation Example 54 and by the reaction and treatment in the same manner as in Example 426, the title compound (56 mg) was obtained via 3-{5-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}-1-(4-methoxybenzyl)-4,4-dimethylimidazolidin-2-one (119 mg).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08816079B2
Source datasetuspto-grants-2014_08
ORD IDord-b085cb32ddad4008b6aa11ad3ea18362
Source noteuspto-grants-2014_08